full screen Ozempic, which is actually a diabetes drug, is used as a treatment for obesity. Archive image. Photo: Joe O’Connal/The Canadian Press/AP
The European Medicines Agency EMA is reviewing obesity drugs following suspicions that appetite suppressant drugs such as Ozempic and Saxenda may increase the risk of suicidal thoughts and self-harming behaviour, writes Dagens Nyheter.
150 similar cases of suspected side effects linked to the drugs have been reported, of which two from Sweden.
Ozempic has attracted attention on social media, where influencers and celebrities have shared that they lost weight with the help of the medicine.